Legislation
- Title
- Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product
- Sponsored by
- Delegate Shetty
- Status
- Approved by the Governor - Chapter 162
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Requiring a pharmacist, or the pharmacist's designee who is under certain supervision, to inform a consumer of the availability of a therapeutically equivalent brand name drug that is the lowest cost alternative to the originally prescribed drug or device and the cost difference between the equivalent drug or device and the prescribed drug; requiring a pharmacist to provide written notice, or to maintain a record that indicates a patient was notified in writing or orally, that the generic product is equivalent to the brand name product; etc.
Committees
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
12-504 )
Last Updated: 5/20/2021 5:40 PM